Congress Presses FDA To Speak Up On OTC/Supplement Combos
This article was originally published in The Pink Sheet Daily
Executive Summary
Inquiry spurred by Bayer Aspirin with Heart Advantage, which combines aspirin with plant phytosterols and claims to lower cholesterol.
You may also be interested in...
Bayer Warning Letters Reinforce FDA Ban On Supplement/Drug Combinations
FDA could seize combo products and request an injunction against distribution and sales if Bayer fails to satisfy agency questions.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.